The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Monteris Medical sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Monteris Medical is a medical device company that designs, develops, and markets innovative MRI guided, laser- based systems for the surgical removal of brain tumors and brain lesions. The company provides Monteris NeuroBlate system, an invasive cranial access system that allows a robotic interface for the delivery of laser energy. NeuroBlate system is used for the treatment of neurological lesions, including brain tumors, epileptic foci, and radiation necrosis. Monteris is headquartered in Minnetonka, Minnesota, the US.
The key metrics of Monteris Medical related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Monteris Medical is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Monteris Medical.
For a detailed understanding of the performance of Monteris Medical, buy the report here.